| 0 |
TORUS FRACTURE |
37 |
0.5211 |
| 1 |
ANTI-SACCHAROMYCES CEREVISIAE ANTIBODY |
4 |
0.5000 |
| 2 |
CYSTIC FIBROSIS GASTROINTESTINAL DISEASE |
3 |
0.1200 |
| 3 |
PNEUMONIA SALMONELLA |
4 |
0.0851 |
| 4 |
ATYPICAL MYCOBACTERIAL LOWER RESPIRATORY TRACT INFECTION |
4 |
0.0556 |
| 5 |
ECHOPRAXIA |
3 |
0.0462 |
| 6 |
MEDULLOBLASTOMA |
5 |
0.0336 |
| 7 |
CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION |
27 |
0.0302 |
| 8 |
SYMPTOM MASKED |
19 |
0.0261 |
| 9 |
GASTRIC HYPOMOTILITY |
7 |
0.0228 |
| 10 |
INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS |
117 |
0.0215 |
| 11 |
OBSESSIVE-COMPULSIVE SYMPTOM |
7 |
0.0190 |
| 12 |
OESOPHAGEAL SPASM |
34 |
0.0184 |
| 13 |
ASTROCYTOMA, LOW GRADE |
3 |
0.0176 |
| 14 |
ACUTE MYOPIA |
3 |
0.0165 |
| 15 |
OBSTRUCTIVE SLEEP APNOEA SYNDROME |
23 |
0.0158 |
| 16 |
INJECTION SITE PLAQUE |
3 |
0.0143 |
| 17 |
FEEDING TUBE USER |
5 |
0.0137 |
| 18 |
CARCINOID CRISIS |
3 |
0.0133 |
| 19 |
BUTTERFLY RASH |
13 |
0.0128 |
| 20 |
JUVENILE IDIOPATHIC ARTHRITIS |
31 |
0.0127 |
| 21 |
APALLIC SYNDROME |
9 |
0.0124 |
| 22 |
CYSTIC FIBROSIS |
68 |
0.0123 |
| 23 |
HALLUCINATION, TACTILE |
8 |
0.0120 |
| 24 |
LOWER RESPIRATORY TRACT INFECTION FUNGAL |
4 |
0.0103 |
| 25 |
SEROTONIN SYNDROME |
192 |
0.0100 |
| 26 |
INFECTIVE EXACERBATION OF BRONCHIECTASIS |
3 |
0.0098 |
| 27 |
CENTRAL OBESITY |
7 |
0.0095 |
| 28 |
CLONUS |
24 |
0.0088 |
| 29 |
PULMONARY FUNCTION TEST DECREASED |
37 |
0.0084 |
| 30 |
OESOPHAGEAL PAIN |
33 |
0.0083 |
| 31 |
GROWTH RETARDATION |
24 |
0.0081 |
| 32 |
NECROTISING OESOPHAGITIS |
4 |
0.0080 |
| 33 |
ADHESIVE TAPE USE |
3 |
0.0078 |
| 34 |
GROWTH HORMONE DEFICIENCY |
3 |
0.0076 |
| 35 |
BONE DEMINERALISATION |
8 |
0.0076 |
| 36 |
PUPIL FIXED |
13 |
0.0075 |
| 37 |
NEUROGENIC SHOCK |
4 |
0.0074 |
| 38 |
GLUCOCORTICOID DEFICIENCY |
3 |
0.0071 |
| 39 |
RHINOVIRUS INFECTION |
26 |
0.0067 |
| 40 |
LIMB ASYMMETRY |
5 |
0.0065 |
| 41 |
JOINT DESTRUCTION |
10 |
0.0064 |
| 42 |
HYPERAMMONAEMIC ENCEPHALOPATHY |
11 |
0.0063 |
| 43 |
BODY HEIGHT INCREASED |
3 |
0.0061 |
| 44 |
CHRONIC SINUSITIS |
23 |
0.0061 |
| 45 |
SEIZURE CLUSTER |
5 |
0.0060 |
| 46 |
DISTURBANCE IN SOCIAL BEHAVIOUR |
14 |
0.0059 |
| 47 |
HYPOPERFUSION |
6 |
0.0057 |
| 48 |
INFUSION SITE DISCHARGE |
10 |
0.0057 |
| 49 |
VASCULAR DEVICE INFECTION |
24 |
0.0053 |
| 50 |
GASTROINTESTINAL SURGERY |
4 |
0.0052 |
| 51 |
DIARRHOEA INFECTIOUS |
4 |
0.0051 |
| 52 |
CROUP INFECTIOUS |
4 |
0.0051 |
| 53 |
BEZOAR |
7 |
0.0051 |
| 54 |
HYPERREFLEXIA |
17 |
0.0049 |
| 55 |
NASAL POLYPS |
24 |
0.0049 |
| 56 |
DIAPHRAGMATIC HERNIA |
3 |
0.0048 |
| 57 |
LYMPHOEDEMA |
33 |
0.0048 |
| 58 |
SYSTOLIC DYSFUNCTION |
5 |
0.0047 |
| 59 |
CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER |
5 |
0.0047 |
| 60 |
ENTEROVIRUS INFECTION |
4 |
0.0046 |
| 61 |
DRUG CLEARANCE DECREASED |
6 |
0.0046 |
| 62 |
GASTROSTOMY |
7 |
0.0045 |
| 63 |
HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME |
5 |
0.0045 |
| 64 |
POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME |
6 |
0.0044 |
| 65 |
IMMOBILE |
19 |
0.0043 |
| 66 |
MAST CELL ACTIVATION SYNDROME |
6 |
0.0043 |
| 67 |
SLEEP-RELATED EATING DISORDER |
4 |
0.0043 |
| 68 |
INFUSION SITE BRUISING |
9 |
0.0042 |
| 69 |
CLONIC CONVULSION |
3 |
0.0041 |
| 70 |
MASTOIDITIS |
4 |
0.0041 |
| 71 |
POSTICTAL STATE |
4 |
0.0038 |
| 72 |
COGWHEEL RIGIDITY |
4 |
0.0038 |
| 73 |
REGURGITATION |
13 |
0.0038 |
| 74 |
SMALL INTESTINAL STENOSIS |
4 |
0.0038 |
| 75 |
OBSESSIVE-COMPULSIVE DISORDER |
30 |
0.0037 |
| 76 |
REBOUND ACID HYPERSECRETION |
11 |
0.0036 |
| 77 |
QUADRIPARESIS |
6 |
0.0036 |
| 78 |
BRONCHIAL OBSTRUCTION |
5 |
0.0036 |
| 79 |
GLUTEN SENSITIVITY |
5 |
0.0035 |
| 80 |
INFUSION SITE PRURITUS |
11 |
0.0035 |
| 81 |
HYPOTHALAMO-PITUITARY DISORDER |
5 |
0.0034 |
| 82 |
AUTONOMIC NERVOUS SYSTEM IMBALANCE |
10 |
0.0034 |
| 83 |
BLOOD ALBUMIN INCREASED |
3 |
0.0034 |
| 84 |
INFUSION SITE HAEMORRHAGE |
11 |
0.0033 |
| 85 |
ATRIAL TACHYCARDIA |
7 |
0.0033 |
| 86 |
HEART TRANSPLANT |
3 |
0.0033 |
| 87 |
HAEMATOCRIT ABNORMAL |
4 |
0.0033 |
| 88 |
HYPERPARATHYROIDISM SECONDARY |
8 |
0.0032 |
| 89 |
INFUSION SITE NODULE |
3 |
0.0031 |
| 90 |
INFUSION SITE REACTION |
9 |
0.0030 |
| 91 |
TONIC CONVULSION |
4 |
0.0028 |
| 92 |
INFUSION SITE MASS |
3 |
0.0028 |
| 93 |
FAT TISSUE INCREASED |
4 |
0.0028 |
| 94 |
PARAINFLUENZAE VIRUS INFECTION |
4 |
0.0026 |
| 95 |
MYOGLOBIN BLOOD INCREASED |
4 |
0.0026 |
| 96 |
PNEUMONIA PSEUDOMONAL |
4 |
0.0026 |
| 97 |
HYPERAMMONAEMIA |
13 |
0.0026 |
| 98 |
NEPHROGENIC ANAEMIA |
12 |
0.0026 |
| 99 |
ELECTROCARDIOGRAM T WAVE ABNORMAL |
4 |
0.0026 |
| 100 |
PYELONEPHRITIS ACUTE |
5 |
0.0025 |
| 101 |
SLEEP APNOEA SYNDROME |
48 |
0.0025 |
| 102 |
ANTICHOLINERGIC SYNDROME |
4 |
0.0025 |
| 103 |
WEIGHT ABNORMAL |
6 |
0.0025 |
| 104 |
STARING |
6 |
0.0025 |
| 105 |
SLOW SPEECH |
6 |
0.0025 |
| 106 |
OTITIS MEDIA |
8 |
0.0024 |
| 107 |
ILLUSION |
4 |
0.0024 |
| 108 |
EDUCATIONAL PROBLEM |
4 |
0.0024 |
| 109 |
INFUSION SITE SWELLING |
15 |
0.0024 |
| 110 |
HYPERTHERMIA |
18 |
0.0024 |
| 111 |
ANGLE CLOSURE GLAUCOMA |
6 |
0.0023 |
| 112 |
SPUTUM INCREASED |
5 |
0.0023 |
| 113 |
OTORRHOEA |
4 |
0.0023 |
| 114 |
HAEMODYNAMIC INSTABILITY |
17 |
0.0022 |
| 115 |
BEHAVIOUR DISORDER |
12 |
0.0022 |
| 116 |
NASAL OEDEMA |
4 |
0.0022 |
| 117 |
CARBON DIOXIDE INCREASED |
3 |
0.0022 |
| 118 |
BODY TEMPERATURE ABNORMAL |
4 |
0.0022 |
| 119 |
EOSINOPHILIC OESOPHAGITIS |
6 |
0.0022 |
| 120 |
OTOTOXICITY |
4 |
0.0022 |
| 121 |
MALNUTRITION |
24 |
0.0021 |
| 122 |
PRE-EXISTING CONDITION IMPROVED |
13 |
0.0021 |
| 123 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
18 |
0.0021 |
| 124 |
END STAGE RENAL DISEASE |
37 |
0.0020 |
| 125 |
DRUG DELIVERY SYSTEM ISSUE |
4 |
0.0020 |
| 126 |
PNEUMONIA STAPHYLOCOCCAL |
4 |
0.0020 |
| 127 |
BLOOD IMMUNOGLOBULIN G DECREASED |
5 |
0.0020 |
| 128 |
GASTROINTESTINAL TUBE INSERTION |
5 |
0.0020 |
| 129 |
INJECTION SITE PARAESTHESIA |
3 |
0.0020 |
| 130 |
INFUSION SITE PAIN |
25 |
0.0019 |
| 131 |
ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT |
5 |
0.0019 |
| 132 |
PULSELESS ELECTRICAL ACTIVITY |
8 |
0.0019 |
| 133 |
PSEUDOMONAS INFECTION |
16 |
0.0019 |
| 134 |
ELECTROCARDIOGRAM ST SEGMENT DEPRESSION |
4 |
0.0018 |
| 135 |
INTESTINAL ISCHAEMIA |
10 |
0.0018 |
| 136 |
FOOD AVERSION |
3 |
0.0018 |
| 137 |
GAZE PALSY |
3 |
0.0018 |
| 138 |
RESPIRATORY SYMPTOM |
5 |
0.0018 |
| 139 |
PHARYNGITIS STREPTOCOCCAL |
19 |
0.0018 |
| 140 |
DROOLING |
12 |
0.0017 |
| 141 |
PERIORBITAL OEDEMA |
9 |
0.0017 |
| 142 |
LUNG TRANSPLANT |
6 |
0.0017 |
| 143 |
MENTAL STATUS CHANGES |
47 |
0.0017 |
| 144 |
FIBROMYALGIA |
41 |
0.0017 |
| 145 |
MYOPIA |
4 |
0.0017 |
| 146 |
SINUS OPERATION |
4 |
0.0017 |
| 147 |
DISORGANISED SPEECH |
3 |
0.0016 |
| 148 |
STREPTOCOCCAL INFECTION |
9 |
0.0016 |
| 149 |
PNEUMONIA ASPIRATION |
40 |
0.0016 |
| 150 |
PERIORBITAL SWELLING |
9 |
0.0016 |
| 151 |
BLOOD BICARBONATE DECREASED |
3 |
0.0016 |
| 152 |
VENTRICULAR HYPOKINESIA |
5 |
0.0016 |
| 153 |
INFUSION SITE ERYTHEMA |
13 |
0.0015 |
| 154 |
MULTIPLE ALLERGIES |
12 |
0.0015 |
| 155 |
ECONOMIC PROBLEM |
23 |
0.0015 |
| 156 |
APPETITE DISORDER |
10 |
0.0015 |
| 157 |
ALLERGIC REACTION TO EXCIPIENT |
3 |
0.0015 |
| 158 |
MUSCLE RIGIDITY |
18 |
0.0015 |
| 159 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
4 |
0.0015 |
| 160 |
MIOSIS |
12 |
0.0015 |
| 161 |
ANHEDONIA |
39 |
0.0015 |
| 162 |
SEDATION |
38 |
0.0014 |
| 163 |
INTRACRANIAL PRESSURE INCREASED |
8 |
0.0014 |
| 164 |
NEUROLEPTIC MALIGNANT SYNDROME |
17 |
0.0014 |
| 165 |
BUNDLE BRANCH BLOCK LEFT |
6 |
0.0014 |
| 166 |
PERSONALITY CHANGE |
13 |
0.0014 |
| 167 |
HYPERTONIA |
8 |
0.0014 |
| 168 |
DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
10 |
0.0014 |
| 169 |
PYODERMA GANGRENOSUM |
5 |
0.0014 |
| 170 |
HORDEOLUM |
6 |
0.0014 |
| 171 |
CEREBELLAR SYNDROME |
3 |
0.0014 |
| 172 |
FEMORAL NECK FRACTURE |
7 |
0.0014 |
| 173 |
AGITATION |
100 |
0.0014 |
| 174 |
MOOD SWINGS |
43 |
0.0013 |
| 175 |
SINUS TACHYCARDIA |
19 |
0.0013 |
| 176 |
BLOOD CULTURE POSITIVE |
4 |
0.0013 |
| 177 |
METABOLIC ENCEPHALOPATHY |
4 |
0.0013 |
| 178 |
BLOOD LACTIC ACID INCREASED |
7 |
0.0013 |
| 179 |
CENTRAL VENOUS CATHETERISATION |
4 |
0.0013 |
| 180 |
MYDRIASIS |
17 |
0.0013 |
| 181 |
DISTRIBUTIVE SHOCK |
3 |
0.0013 |
| 182 |
GASTROINTESTINAL MOTILITY DISORDER |
7 |
0.0013 |
| 183 |
VIRAL INFECTION |
43 |
0.0013 |
| 184 |
EAR INFECTION |
34 |
0.0013 |
| 185 |
PNEUMONIA FUNGAL |
5 |
0.0013 |
| 186 |
RESTLESSNESS |
46 |
0.0013 |
| 187 |
GASTROINTESTINAL OBSTRUCTION |
3 |
0.0012 |
| 188 |
LIQUID PRODUCT PHYSICAL ISSUE |
9 |
0.0012 |
| 189 |
LUPUS-LIKE SYNDROME |
11 |
0.0012 |
| 190 |
SOCIAL AVOIDANT BEHAVIOUR |
7 |
0.0012 |
| 191 |
HYPERNATRAEMIA |
6 |
0.0012 |
| 192 |
RED CELL DISTRIBUTION WIDTH INCREASED |
5 |
0.0012 |
| 193 |
PNEUMOTHORAX |
19 |
0.0012 |
| 194 |
POST-TRAUMATIC STRESS DISORDER |
8 |
0.0012 |
| 195 |
CYSTITIS |
38 |
0.0012 |
| 196 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
20 |
0.0012 |
| 197 |
IMPAIRED GASTRIC EMPTYING |
16 |
0.0012 |
| 198 |
CANCER PAIN |
3 |
0.0012 |
| 199 |
ELECTROCARDIOGRAM QT PROLONGED |
42 |
0.0012 |
| 200 |
ATRIOVENTRICULAR BLOCK |
9 |
0.0012 |
| 201 |
CHRONIC KIDNEY DISEASE |
88 |
0.0012 |
| 202 |
PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
7 |
0.0011 |
| 203 |
IRRITABILITY |
69 |
0.0011 |
| 204 |
PRODUCT ADMINISTRATION INTERRUPTED |
9 |
0.0011 |
| 205 |
SCOLIOSIS |
7 |
0.0011 |
| 206 |
RESPIRATORY RATE INCREASED |
10 |
0.0011 |
| 207 |
BONE DENSITY DECREASED |
35 |
0.0011 |
| 208 |
CARDIOGENIC SHOCK |
16 |
0.0011 |
| 209 |
MIGRAINE |
105 |
0.0011 |
| 210 |
SCREAMING |
7 |
0.0011 |
| 211 |
MYOCLONUS |
13 |
0.0011 |
| 212 |
AUTISM SPECTRUM DISORDER |
6 |
0.0011 |
| 213 |
ISCHAEMIA |
5 |
0.0011 |
| 214 |
GENERALISED TONIC-CLONIC SEIZURE |
18 |
0.0011 |
| 215 |
FEEDING DISORDER |
22 |
0.0011 |
| 216 |
PRODUCT DISTRIBUTION ISSUE |
10 |
0.0011 |
| 217 |
INTENTIONAL OVERDOSE |
69 |
0.0011 |
| 218 |
ENDOTRACHEAL INTUBATION |
3 |
0.0011 |
| 219 |
PRODUCT PREPARATION ISSUE |
7 |
0.0011 |
| 220 |
STATUS EPILEPTICUS |
12 |
0.0011 |
| 221 |
SNORING |
4 |
0.0011 |
| 222 |
PULSE ABSENT |
5 |
0.0011 |
| 223 |
IMPAIRED QUALITY OF LIFE |
15 |
0.0010 |
| 224 |
HYPERTONIC BLADDER |
3 |
0.0010 |
| 225 |
ADENOVIRUS INFECTION |
3 |
0.0010 |
| 226 |
HYPOALBUMINAEMIA |
8 |
0.0010 |
| 227 |
SPINAL CORD COMPRESSION |
4 |
0.0010 |
| 228 |
MOOD ALTERED |
28 |
0.0010 |
| 229 |
PSYCHOMOTOR HYPERACTIVITY |
17 |
0.0010 |
| 230 |
WITHDRAWAL SYNDROME |
43 |
0.0010 |
| 231 |
RESPIRATION ABNORMAL |
7 |
0.0010 |
| 232 |
BREATH SOUNDS ABNORMAL |
5 |
0.0010 |
| 233 |
GASTROINTESTINAL INFECTION |
9 |
0.0010 |
| 234 |
GASTROENTERITIS VIRAL |
18 |
0.0010 |
| 235 |
CRANIOCEREBRAL INJURY |
3 |
0.0010 |
| 236 |
PNEUMONIA BACTERIAL |
9 |
0.0010 |
| 237 |
DELIRIUM |
34 |
0.0010 |
| 238 |
AGGRESSION |
49 |
0.0010 |
| 239 |
IRON DEFICIENCY ANAEMIA |
9 |
0.0010 |
| 240 |
SUICIDAL BEHAVIOUR |
4 |
0.0010 |
| 241 |
TINNITUS |
44 |
0.0010 |
| 242 |
STOMATITIS |
58 |
0.0010 |
| 243 |
WEIGHT FLUCTUATION |
10 |
0.0010 |
| 244 |
PARTIAL SEIZURES |
5 |
0.0010 |
| 245 |
HYPOCALCAEMIA |
18 |
0.0010 |
| 246 |
ATTENTION DEFICIT HYPERACTIVITY DISORDER |
4 |
0.0009 |
| 247 |
NYSTAGMUS |
5 |
0.0009 |
| 248 |
INCORRECT DRUG ADMINISTRATION RATE |
4 |
0.0009 |
| 249 |
NASAL CONGESTION |
55 |
0.0009 |
| 250 |
STAPHYLOCOCCAL BACTERAEMIA |
4 |
0.0009 |
| 251 |
HYDROCEPHALUS |
5 |
0.0009 |
| 252 |
TIC |
5 |
0.0009 |
| 253 |
ACIDOSIS |
7 |
0.0009 |
| 254 |
INSURANCE ISSUE |
14 |
0.0009 |
| 255 |
SOMNAMBULISM |
6 |
0.0009 |
| 256 |
FAECALOMA |
5 |
0.0009 |
| 257 |
HAEMORRHAGIC ANAEMIA |
4 |
0.0009 |
| 258 |
NECROSIS |
5 |
0.0009 |
| 259 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
49 |
0.0009 |
| 260 |
BRONCHITIS |
66 |
0.0009 |
| 261 |
BRONCHIECTASIS |
6 |
0.0009 |
| 262 |
RHABDOMYOLYSIS |
37 |
0.0009 |
| 263 |
PAPILLOEDEMA |
4 |
0.0009 |
| 264 |
EYE INFECTION |
10 |
0.0009 |
| 265 |
INITIAL INSOMNIA |
9 |
0.0009 |
| 266 |
HALLUCINATION |
66 |
0.0009 |
| 267 |
AUTOIMMUNE HAEMOLYTIC ANAEMIA |
3 |
0.0009 |
| 268 |
NEUROLOGICAL SYMPTOM |
5 |
0.0009 |
| 269 |
HEPATIC FIBROSIS |
3 |
0.0009 |
| 270 |
FUNGAL INFECTION |
29 |
0.0009 |
| 271 |
HYPOPNOEA |
3 |
0.0009 |
| 272 |
RESPIRATORY FAILURE |
63 |
0.0009 |
| 273 |
SEIZURE |
99 |
0.0009 |
| 274 |
NEPHROPATHY |
8 |
0.0009 |
| 275 |
VAGINAL INFECTION |
4 |
0.0008 |
| 276 |
UPPER-AIRWAY COUGH SYNDROME |
7 |
0.0008 |
| 277 |
BLOOD IRON DECREASED |
10 |
0.0008 |
| 278 |
CONJUNCTIVAL HYPERAEMIA |
3 |
0.0008 |
| 279 |
VIRAL UPPER RESPIRATORY TRACT INFECTION |
4 |
0.0008 |
| 280 |
HEREDITARY ANGIOEDEMA |
9 |
0.0008 |
| 281 |
SYMPTOM RECURRENCE |
5 |
0.0008 |
| 282 |
CLOSTRIDIUM DIFFICILE INFECTION |
18 |
0.0008 |
| 283 |
HYPOPHAGIA |
21 |
0.0008 |
| 284 |
INTENTIONAL UNDERDOSE |
6 |
0.0008 |
| 285 |
INFLAMMATORY BOWEL DISEASE |
8 |
0.0008 |
| 286 |
MUSCLE SPASTICITY |
10 |
0.0008 |
| 287 |
CARDIAC MURMUR |
7 |
0.0008 |
| 288 |
SINUS DISORDER |
16 |
0.0008 |
| 289 |
CARDIAC DYSFUNCTION |
3 |
0.0008 |
| 290 |
DEVICE MECHANICAL ISSUE |
11 |
0.0008 |
| 291 |
SINUSITIS |
82 |
0.0008 |
| 292 |
CRYING |
29 |
0.0008 |
| 293 |
HEPATIC NECROSIS |
3 |
0.0008 |
| 294 |
APHONIA |
11 |
0.0008 |
| 295 |
GASTRIC INFECTION |
3 |
0.0008 |
| 296 |
PETIT MAL EPILEPSY |
4 |
0.0008 |
| 297 |
ENTERITIS |
5 |
0.0008 |
| 298 |
SEASONAL ALLERGY |
11 |
0.0008 |
| 299 |
DECREASED APPETITE |
180 |
0.0008 |
| 300 |
VASCULITIS |
9 |
0.0008 |
| 301 |
FLUID RETENTION |
39 |
0.0008 |
| 302 |
HYPOXIA |
27 |
0.0008 |
| 303 |
APLASTIC ANAEMIA |
4 |
0.0008 |
| 304 |
CATATONIA |
4 |
0.0008 |
| 305 |
UPPER RESPIRATORY TRACT INFECTION |
35 |
0.0008 |
| 306 |
TRICUSPID VALVE INCOMPETENCE |
6 |
0.0008 |
| 307 |
HYPERPHAGIA |
3 |
0.0008 |
| 308 |
BACTERIAL INFECTION |
14 |
0.0007 |
| 309 |
MIDDLE INSOMNIA |
14 |
0.0007 |
| 310 |
LEFT VENTRICULAR DYSFUNCTION |
5 |
0.0007 |
| 311 |
RHINITIS |
6 |
0.0007 |
| 312 |
ENURESIS |
3 |
0.0007 |
| 313 |
HOSPITALISATION |
113 |
0.0007 |
| 314 |
RESPIRATORY TRACT INFECTION |
19 |
0.0007 |
| 315 |
OSTEOPOROSIS |
30 |
0.0007 |
| 316 |
ACUTE RESPIRATORY FAILURE |
14 |
0.0007 |
| 317 |
OSTEOPENIA |
11 |
0.0007 |
| 318 |
OBSTRUCTIVE AIRWAYS DISORDER |
8 |
0.0007 |
| 319 |
HAEMOPTYSIS |
20 |
0.0007 |
| 320 |
LETHARGY |
41 |
0.0007 |
| 321 |
DRUG INTERACTION |
113 |
0.0007 |
| 322 |
THERAPY CHANGE |
7 |
0.0007 |
| 323 |
SUICIDE ATTEMPT |
43 |
0.0007 |
| 324 |
REBOUND EFFECT |
8 |
0.0007 |
| 325 |
RETCHING |
15 |
0.0007 |
| 326 |
POOR QUALITY DEVICE USED |
7 |
0.0007 |
| 327 |
HYPERSOMNIA |
20 |
0.0007 |
| 328 |
EXERCISE TOLERANCE DECREASED |
4 |
0.0007 |
| 329 |
HYPERVENTILATION |
4 |
0.0007 |
| 330 |
PULMONARY ARTERIAL HYPERTENSION |
10 |
0.0007 |
| 331 |
RALES |
4 |
0.0007 |
| 332 |
INCREASED APPETITE |
13 |
0.0007 |
| 333 |
LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR |
6 |
0.0007 |
| 334 |
HYPOPHOSPHATAEMIA |
5 |
0.0007 |
| 335 |
ATAXIA |
8 |
0.0007 |
| 336 |
SINUS HEADACHE |
4 |
0.0007 |
| 337 |
RHINORRHOEA |
43 |
0.0007 |
| 338 |
ANXIETY |
189 |
0.0007 |
| 339 |
CONTRAINDICATED PRODUCT ADMINISTERED |
20 |
0.0007 |
| 340 |
CLOSTRIDIUM DIFFICILE COLITIS |
7 |
0.0007 |
| 341 |
HAEMOGLOBIN INCREASED |
3 |
0.0007 |
| 342 |
ABNORMAL BEHAVIOUR |
26 |
0.0007 |
| 343 |
TACHYCARDIA |
58 |
0.0007 |
| 344 |
SLEEP DISORDER |
46 |
0.0007 |
| 345 |
DECREASED ACTIVITY |
7 |
0.0006 |
| 346 |
EMOTIONAL DISORDER |
20 |
0.0006 |
| 347 |
ABDOMINAL PAIN |
150 |
0.0006 |
| 348 |
LUNG INFECTION |
10 |
0.0006 |
| 349 |
INFUSION SITE EXTRAVASATION |
4 |
0.0006 |
| 350 |
DEVICE INFORMATION OUTPUT ISSUE |
5 |
0.0006 |
| 351 |
ACUTE KIDNEY INJURY |
98 |
0.0006 |
| 352 |
BODY TEMPERATURE INCREASED |
13 |
0.0006 |
| 353 |
CYANOSIS |
10 |
0.0006 |
| 354 |
WEIGHT DECREASED |
177 |
0.0006 |
| 355 |
PNEUMONIA |
205 |
0.0006 |
| 356 |
DENTAL CARIES |
7 |
0.0006 |
| 357 |
GASTRIC ULCER |
12 |
0.0006 |
| 358 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
30 |
0.0006 |
| 359 |
ATELECTASIS |
6 |
0.0006 |
| 360 |
COMPLICATION ASSOCIATED WITH DEVICE |
9 |
0.0006 |
| 361 |
THROMBOTIC MICROANGIOPATHY |
6 |
0.0006 |
| 362 |
PHARYNGEAL SWELLING |
6 |
0.0006 |
| 363 |
INFECTION |
88 |
0.0006 |
| 364 |
HYPERVOLAEMIA |
3 |
0.0006 |
| 365 |
HAIR DISORDER |
5 |
0.0006 |
| 366 |
INFLAMMATORY MARKER INCREASED |
3 |
0.0006 |
| 367 |
RESTLESS LEGS SYNDROME |
11 |
0.0006 |
| 368 |
ABDOMINAL TENDERNESS |
3 |
0.0006 |
| 369 |
FLUID INTAKE REDUCED |
3 |
0.0006 |
| 370 |
MENINGITIS |
4 |
0.0006 |
| 371 |
CONJUNCTIVITIS |
11 |
0.0006 |
| 372 |
SINUS CONGESTION |
8 |
0.0006 |
| 373 |
DRUG LEVEL DECREASED |
6 |
0.0006 |
| 374 |
TACHYPNOEA |
8 |
0.0006 |
| 375 |
AKATHISIA |
8 |
0.0006 |
| 376 |
ELECTROCARDIOGRAM QRS COMPLEX PROLONGED |
3 |
0.0006 |
| 377 |
URTICARIA |
98 |
0.0006 |
| 378 |
VITAMIN D DECREASED |
5 |
0.0006 |
| 379 |
LIVER FUNCTION TEST ABNORMAL |
17 |
0.0006 |
| 380 |
UNRESPONSIVE TO STIMULI |
15 |
0.0006 |
| 381 |
THERAPY NON-RESPONDER |
26 |
0.0006 |
| 382 |
FAILURE TO THRIVE |
3 |
0.0006 |
| 383 |
EYE DISCHARGE |
6 |
0.0006 |
| 384 |
DEHYDRATION |
77 |
0.0006 |
| 385 |
SPINAL OSTEOARTHRITIS |
5 |
0.0006 |
| 386 |
DERMATITIS ATOPIC |
30 |
0.0006 |
| 387 |
SHOCK |
13 |
0.0006 |
| 388 |
ABDOMINAL PAIN UPPER |
116 |
0.0006 |
| 389 |
COMPRESSION FRACTURE |
3 |
0.0006 |
| 390 |
INJECTION SITE DISCHARGE |
3 |
0.0006 |
| 391 |
TOXICITY TO VARIOUS AGENTS |
94 |
0.0006 |
| 392 |
CARDIAC ARREST |
46 |
0.0006 |
| 393 |
ANAL ABSCESS |
3 |
0.0006 |
| 394 |
GINGIVITIS |
3 |
0.0006 |
| 395 |
ERYTHEMA OF EYELID |
3 |
0.0006 |
| 396 |
VISUAL FIELD DEFECT |
4 |
0.0006 |
| 397 |
DEVICE LEAKAGE |
24 |
0.0006 |
| 398 |
HYPERHIDROSIS |
71 |
0.0006 |
| 399 |
ASPIRATION |
6 |
0.0005 |
| 400 |
MAJOR DEPRESSION |
4 |
0.0005 |
| 401 |
SURGERY |
32 |
0.0005 |
| 402 |
HIATUS HERNIA |
7 |
0.0005 |
| 403 |
RENAL INJURY |
16 |
0.0005 |
| 404 |
BLOOD UREA INCREASED |
9 |
0.0005 |
| 405 |
INTENTIONAL PRODUCT MISUSE |
47 |
0.0005 |
| 406 |
PRODUCT USE IN UNAPPROVED INDICATION |
133 |
0.0005 |
| 407 |
MUCOSAL INFLAMMATION |
14 |
0.0005 |
| 408 |
GASTROOESOPHAGEAL REFLUX DISEASE |
43 |
0.0005 |
| 409 |
GASTRITIS |
14 |
0.0005 |
| 410 |
METABOLIC ACIDOSIS |
17 |
0.0005 |
| 411 |
INTESTINAL OBSTRUCTION |
20 |
0.0005 |
| 412 |
BLOOD SODIUM DECREASED |
10 |
0.0005 |
| 413 |
PRODUCT DOSE OMISSION IN ERROR |
15 |
0.0005 |
| 414 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
15 |
0.0005 |
| 415 |
FLATULENCE |
30 |
0.0005 |
| 416 |
DRUG ABUSE |
44 |
0.0005 |
| 417 |
SPUTUM DISCOLOURED |
5 |
0.0005 |
| 418 |
DERMATITIS CONTACT |
6 |
0.0005 |
| 419 |
SUPRAVENTRICULAR TACHYCARDIA |
5 |
0.0005 |
| 420 |
DISSOCIATION |
4 |
0.0005 |
| 421 |
HALLUCINATION, VISUAL |
11 |
0.0005 |
| 422 |
COUGH |
146 |
0.0005 |
| 423 |
RENAL FAILURE CHRONIC |
4 |
0.0005 |
| 424 |
INFLUENZA |
58 |
0.0005 |
| 425 |
HYPOKALAEMIA |
24 |
0.0005 |
| 426 |
RENAL FAILURE |
69 |
0.0005 |
| 427 |
ELECTROLYTE IMBALANCE |
6 |
0.0005 |
| 428 |
HYPOVOLAEMIA |
3 |
0.0005 |
| 429 |
VITAMIN D DEFICIENCY |
5 |
0.0005 |
| 430 |
BRAIN FOG |
8 |
0.0005 |
| 431 |
RENAL TUBULAR NECROSIS |
5 |
0.0005 |
| 432 |
DECREASED INTEREST |
3 |
0.0005 |
| 433 |
VOMITING |
239 |
0.0005 |
| 434 |
ASPARTATE AMINOTRANSFERASE INCREASED |
27 |
0.0005 |
| 435 |
GLUCOSE TOLERANCE IMPAIRED |
3 |
0.0005 |
| 436 |
HOSPICE CARE |
5 |
0.0005 |
| 437 |
DRUG SCREEN POSITIVE |
4 |
0.0005 |
| 438 |
ILLNESS |
52 |
0.0005 |
| 439 |
DISORIENTATION |
20 |
0.0005 |
| 440 |
ASTHMA |
57 |
0.0005 |
| 441 |
ISCHAEMIC STROKE |
9 |
0.0005 |
| 442 |
GASTROINTESTINAL DISORDER |
45 |
0.0005 |
| 443 |
ATRIAL FLUTTER |
4 |
0.0005 |
| 444 |
TREMOR |
83 |
0.0005 |
| 445 |
OXYGEN SATURATION DECREASED |
28 |
0.0005 |
| 446 |
LEUKOCYTOSIS |
9 |
0.0005 |
| 447 |
LACRIMATION INCREASED |
15 |
0.0005 |
| 448 |
PRODUCT ADMINISTRATION ERROR |
10 |
0.0005 |
| 449 |
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE |
9 |
0.0005 |
| 450 |
INTENTIONAL DOSE OMISSION |
14 |
0.0005 |
| 451 |
MOTOR DYSFUNCTION |
5 |
0.0005 |
| 452 |
PYREXIA |
169 |
0.0005 |
| 453 |
NEUTROPHIL COUNT INCREASED |
5 |
0.0005 |
| 454 |
DEPRESSION |
111 |
0.0005 |
| 455 |
HYPERAESTHESIA |
4 |
0.0005 |
| 456 |
POOR VENOUS ACCESS |
5 |
0.0005 |
| 457 |
MENSTRUAL DISORDER |
4 |
0.0005 |
| 458 |
SEPTIC SHOCK |
21 |
0.0005 |
| 459 |
MENTAL DISORDER |
21 |
0.0005 |
| 460 |
PHOTOPHOBIA |
9 |
0.0005 |
| 461 |
DYSPEPSIA |
47 |
0.0005 |
| 462 |
POOR QUALITY PRODUCT ADMINISTERED |
5 |
0.0005 |
| 463 |
SYNCOPE |
47 |
0.0005 |
| 464 |
PRODUCT DOSE OMISSION ISSUE |
138 |
0.0005 |
| 465 |
INCOHERENT |
3 |
0.0005 |
| 466 |
DRUG SPECIFIC ANTIBODY PRESENT |
3 |
0.0005 |
| 467 |
BIPOLAR DISORDER |
5 |
0.0005 |
| 468 |
KIDNEY INFECTION |
9 |
0.0005 |
| 469 |
TREATMENT NONCOMPLIANCE |
25 |
0.0005 |
| 470 |
TOOTH INFECTION |
6 |
0.0005 |
| 471 |
CORONAVIRUS INFECTION |
3 |
0.0005 |
| 472 |
IMMUNOSUPPRESSION |
4 |
0.0005 |
| 473 |
ANAPHYLACTIC REACTION |
25 |
0.0005 |
| 474 |
DYSPNOEA EXERTIONAL |
17 |
0.0005 |
| 475 |
CONSTIPATION |
98 |
0.0004 |
| 476 |
ENCEPHALOPATHY |
11 |
0.0004 |
| 477 |
QUALITY OF LIFE DECREASED |
6 |
0.0004 |
| 478 |
ORAL PAIN |
10 |
0.0004 |
| 479 |
BLOOD CALCIUM DECREASED |
5 |
0.0004 |
| 480 |
CHROMATURIA |
10 |
0.0004 |
| 481 |
PRODUCTIVE COUGH |
21 |
0.0004 |
| 482 |
HIDRADENITIS |
4 |
0.0004 |
| 483 |
EXOSTOSIS |
4 |
0.0004 |
| 484 |
RIB FRACTURE |
9 |
0.0004 |
| 485 |
BRAIN NEOPLASM |
4 |
0.0004 |
| 486 |
NEOPLASM |
5 |
0.0004 |
| 487 |
RESPIRATORY DISTRESS |
12 |
0.0004 |
| 488 |
TOOTH LOSS |
9 |
0.0004 |
| 489 |
HAIR GROWTH ABNORMAL |
3 |
0.0004 |
| 490 |
BLOOD POTASSIUM DECREASED |
13 |
0.0004 |
| 491 |
VISION BLURRED |
59 |
0.0004 |
| 492 |
MASS |
6 |
0.0004 |
| 493 |
LUNG DISORDER |
21 |
0.0004 |
| 494 |
INSOMNIA |
114 |
0.0004 |
| 495 |
PALPITATIONS |
50 |
0.0004 |
| 496 |
SQUAMOUS CELL CARCINOMA |
4 |
0.0004 |
| 497 |
EATING DISORDER |
9 |
0.0004 |
| 498 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
15 |
0.0004 |
| 499 |
DRUG DOSE OMISSION BY DEVICE |
33 |
0.0004 |
| 500 |
BLOOD URINE PRESENT |
8 |
0.0004 |
| 501 |
IRRITABLE BOWEL SYNDROME |
9 |
0.0004 |
| 502 |
ACCIDENT |
5 |
0.0004 |
| 503 |
HYPERLIPIDAEMIA |
5 |
0.0004 |
| 504 |
PERICARDITIS |
7 |
0.0004 |
| 505 |
DRUG PRESCRIBING ERROR |
8 |
0.0004 |
| 506 |
DIABETIC KETOACIDOSIS |
10 |
0.0004 |
| 507 |
SINUS BRADYCARDIA |
4 |
0.0004 |
| 508 |
PRODUCT PRESCRIBING ISSUE |
9 |
0.0004 |
| 509 |
NASOPHARYNGITIS |
76 |
0.0004 |
| 510 |
ADRENAL INSUFFICIENCY |
5 |
0.0004 |
| 511 |
CONDITION AGGRAVATED |
125 |
0.0004 |
| 512 |
DISCOMFORT |
25 |
0.0004 |
| 513 |
OFF LABEL USE |
358 |
0.0004 |
| 514 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
7 |
0.0004 |
| 515 |
FEBRILE NEUTROPENIA |
27 |
0.0004 |
| 516 |
SMALL INTESTINAL OBSTRUCTION |
5 |
0.0004 |
| 517 |
CEREBRAL DISORDER |
3 |
0.0004 |
| 518 |
URINARY INCONTINENCE |
12 |
0.0004 |
| 519 |
HAEMATOCRIT DECREASED |
8 |
0.0004 |
| 520 |
PHARYNGITIS |
5 |
0.0004 |
| 521 |
RESPIRATORY DISORDER |
12 |
0.0004 |
| 522 |
SECRETION DISCHARGE |
5 |
0.0004 |
| 523 |
PRODUCT PHYSICAL ISSUE |
8 |
0.0004 |
| 524 |
BRAIN OEDEMA |
5 |
0.0004 |
| 525 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
7 |
0.0004 |
| 526 |
HYPOTHERMIA |
4 |
0.0004 |
| 527 |
STAPHYLOCOCCAL INFECTION |
13 |
0.0004 |
| 528 |
EYELID PTOSIS |
4 |
0.0004 |
| 529 |
INFUSION RELATED REACTION |
26 |
0.0004 |
| 530 |
DIARRHOEA |
253 |
0.0004 |
| 531 |
ALANINE AMINOTRANSFERASE INCREASED |
24 |
0.0004 |
| 532 |
DYSPHAGIA |
37 |
0.0004 |
| 533 |
FOOD ALLERGY |
3 |
0.0004 |
| 534 |
WHEEZING |
23 |
0.0004 |
| 535 |
INFLAMMATION |
20 |
0.0004 |
| 536 |
CONCUSSION |
3 |
0.0004 |
| 537 |
BRONCHOPULMONARY ASPERGILLOSIS |
3 |
0.0004 |
| 538 |
OSTEOMYELITIS |
7 |
0.0004 |
| 539 |
HYPERBILIRUBINAEMIA |
4 |
0.0004 |
| 540 |
RED BLOOD CELL COUNT DECREASED |
11 |
0.0004 |
| 541 |
ANGER |
13 |
0.0004 |
| 542 |
PRODUCT USE ISSUE |
72 |
0.0004 |
| 543 |
GASTROINTESTINAL INFLAMMATION |
3 |
0.0004 |
| 544 |
PRODUCT DOSE OMISSION |
25 |
0.0004 |
| 545 |
HYPERTENSION |
81 |
0.0004 |
| 546 |
TRANSFUSION |
4 |
0.0004 |
| 547 |
ORAL CANDIDIASIS |
5 |
0.0004 |
| 548 |
SCRATCH |
4 |
0.0004 |
| 549 |
THERAPEUTIC RESPONSE UNEXPECTED |
17 |
0.0004 |
| 550 |
DEPRESSED MOOD |
20 |
0.0004 |
| 551 |
FULL BLOOD COUNT ABNORMAL |
4 |
0.0004 |
| 552 |
BLOOD ALBUMIN DECREASED |
3 |
0.0004 |
| 553 |
HALLUCINATION, AUDITORY |
6 |
0.0004 |
| 554 |
COVID-19 |
66 |
0.0004 |
| 555 |
TUBULOINTERSTITIAL NEPHRITIS |
7 |
0.0004 |
| 556 |
LIVER FUNCTION TEST INCREASED |
8 |
0.0004 |
| 557 |
EMOTIONAL DISTRESS |
45 |
0.0004 |
| 558 |
NEURALGIA |
9 |
0.0004 |
| 559 |
BLOOD POTASSIUM INCREASED |
6 |
0.0004 |
| 560 |
FOOT FRACTURE |
7 |
0.0004 |
| 561 |
DECUBITUS ULCER |
3 |
0.0004 |
| 562 |
DEVICE ISSUE |
33 |
0.0004 |
| 563 |
PALLOR |
10 |
0.0004 |
| 564 |
PULMONARY THROMBOSIS |
4 |
0.0004 |
| 565 |
ABNORMAL FAECES |
3 |
0.0004 |
| 566 |
INTERVERTEBRAL DISC PROTRUSION |
8 |
0.0004 |
| 567 |
MULTIPLE FRACTURES |
6 |
0.0004 |
| 568 |
ESCHERICHIA INFECTION |
3 |
0.0004 |
| 569 |
POST PROCEDURAL COMPLICATION |
7 |
0.0004 |
| 570 |
URINARY TRACT INFECTION |
62 |
0.0004 |
| 571 |
VENTRICULAR FIBRILLATION |
4 |
0.0004 |
| 572 |
HYPOMAGNESAEMIA |
5 |
0.0004 |
| 573 |
ROAD TRAFFIC ACCIDENT |
15 |
0.0004 |
| 574 |
RASH PAPULAR |
8 |
0.0004 |
| 575 |
SKIN INFECTION |
4 |
0.0004 |
| 576 |
NEPHROPATHY TOXIC |
4 |
0.0004 |
| 577 |
CANDIDA INFECTION |
6 |
0.0004 |
| 578 |
PRODUCT AVAILABILITY ISSUE |
8 |
0.0004 |
| 579 |
PRESCRIBED UNDERDOSE |
7 |
0.0004 |
| 580 |
SCAB |
4 |
0.0004 |
| 581 |
DRUG-INDUCED LIVER INJURY |
11 |
0.0004 |
| 582 |
HYPOTENSION |
70 |
0.0003 |
| 583 |
BLOOD MAGNESIUM DECREASED |
3 |
0.0003 |
| 584 |
HYSTERECTOMY |
3 |
0.0003 |
| 585 |
OROPHARYNGEAL PAIN |
32 |
0.0003 |
| 586 |
DEVICE BREAKAGE |
14 |
0.0003 |
| 587 |
ABDOMINAL DISTENSION |
36 |
0.0003 |
| 588 |
MADAROSIS |
4 |
0.0003 |
| 589 |
SEXUAL DYSFUNCTION |
4 |
0.0003 |
| 590 |
CARDIOMYOPATHY |
5 |
0.0003 |
| 591 |
SOMNOLENCE |
68 |
0.0003 |
| 592 |
BLOOD CREATININE INCREASED |
22 |
0.0003 |
| 593 |
PULMONARY HYPERTENSION |
7 |
0.0003 |
| 594 |
POLLAKIURIA |
14 |
0.0003 |
| 595 |
HAEMOLYTIC ANAEMIA |
3 |
0.0003 |
| 596 |
FEELING ABNORMAL |
80 |
0.0003 |
| 597 |
WRIST FRACTURE |
4 |
0.0003 |
| 598 |
DEVELOPMENTAL DELAY |
3 |
0.0003 |
| 599 |
SEPSIS |
37 |
0.0003 |
| 600 |
THERAPEUTIC RESPONSE SHORTENED |
11 |
0.0003 |
| 601 |
LOCALISED INFECTION |
8 |
0.0003 |
| 602 |
CORONARY ARTERY DISEASE |
10 |
0.0003 |
| 603 |
NOCTURIA |
4 |
0.0003 |
| 604 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
13 |
0.0003 |
| 605 |
SKIN LESION |
9 |
0.0003 |
| 606 |
GLOMERULAR FILTRATION RATE DECREASED |
4 |
0.0003 |
| 607 |
ECZEMA |
17 |
0.0003 |
| 608 |
TENDON RUPTURE |
4 |
0.0003 |
| 609 |
HYPERCALCAEMIA |
4 |
0.0003 |
| 610 |
FEELING COLD |
9 |
0.0003 |
| 611 |
MUSCULOSKELETAL CHEST PAIN |
5 |
0.0003 |
| 612 |
WOUND |
9 |
0.0003 |
| 613 |
EJECTION FRACTION DECREASED |
5 |
0.0003 |
| 614 |
WEIGHT INCREASED |
72 |
0.0003 |
| 615 |
PRODUCT DISPENSING ERROR |
7 |
0.0003 |
| 616 |
MYOCARDIAL INFARCTION |
56 |
0.0003 |
| 617 |
DIARRHOEA HAEMORRHAGIC |
3 |
0.0003 |
| 618 |
HEADACHE |
201 |
0.0003 |
| 619 |
THERAPY PARTIAL RESPONDER |
5 |
0.0003 |
| 620 |
DYSARTHRIA |
12 |
0.0003 |
| 621 |
DERMATITIS ALLERGIC |
4 |
0.0003 |
| 622 |
PAIN IN JAW |
9 |
0.0003 |
| 623 |
PRODUCT USE COMPLAINT |
5 |
0.0003 |
| 624 |
SICKLE CELL ANAEMIA WITH CRISIS |
5 |
0.0003 |
| 625 |
OCULAR HYPERAEMIA |
15 |
0.0003 |
| 626 |
HEAD INJURY |
10 |
0.0003 |
| 627 |
TOOTH DISORDER |
7 |
0.0003 |
| 628 |
RESPIRATORY TRACT CONGESTION |
5 |
0.0003 |
| 629 |
EYE INFLAMMATION |
3 |
0.0003 |
| 630 |
RASH |
137 |
0.0003 |
| 631 |
AFFECT LABILITY |
3 |
0.0003 |
| 632 |
HIP FRACTURE |
10 |
0.0003 |
| 633 |
PRESCRIBED OVERDOSE |
6 |
0.0003 |
| 634 |
ABDOMINAL DISCOMFORT |
52 |
0.0003 |
| 635 |
HEART RATE IRREGULAR |
7 |
0.0003 |
| 636 |
MUSCLE TIGHTNESS |
5 |
0.0003 |
| 637 |
EAR PAIN |
6 |
0.0003 |
| 638 |
HAEMORRHOIDS |
6 |
0.0003 |
| 639 |
SUICIDAL IDEATION |
28 |
0.0003 |
| 640 |
NEPHROLITHIASIS |
14 |
0.0003 |
| 641 |
MUSCLE SPASMS |
56 |
0.0003 |
| 642 |
SKIN DISCOLOURATION |
14 |
0.0003 |
| 643 |
NECK PAIN |
17 |
0.0003 |
| 644 |
MUSCLE TWITCHING |
7 |
0.0003 |
| 645 |
SARS-COV-2 TEST POSITIVE |
4 |
0.0003 |
| 646 |
BLOOD PRESSURE ABNORMAL |
6 |
0.0003 |
| 647 |
HYPOTONIA |
3 |
0.0003 |
| 648 |
COAGULOPATHY |
5 |
0.0003 |
| 649 |
PRURITUS |
115 |
0.0003 |
| 650 |
GAIT INABILITY |
10 |
0.0003 |
| 651 |
BRAIN INJURY |
3 |
0.0003 |
| 652 |
CYTOKINE RELEASE SYNDROME |
6 |
0.0003 |
| 653 |
HAIR TEXTURE ABNORMAL |
4 |
0.0003 |
| 654 |
NAUSEA |
236 |
0.0003 |
| 655 |
FATIGUE |
232 |
0.0003 |
| 656 |
FULL BLOOD COUNT DECREASED |
6 |
0.0003 |
| 657 |
EMPHYSEMA |
3 |
0.0003 |
| 658 |
INTENTIONAL PRODUCT USE ISSUE |
26 |
0.0003 |
| 659 |
PRODUCT TASTE ABNORMAL |
4 |
0.0003 |
| 660 |
DYSKINESIA |
12 |
0.0003 |
| 661 |
LIMB INJURY |
8 |
0.0003 |
| 662 |
HEPATIC ENZYME INCREASED |
20 |
0.0003 |
| 663 |
EUPHORIC MOOD |
3 |
0.0003 |
| 664 |
ACUTE HEPATIC FAILURE |
4 |
0.0003 |
| 665 |
DYSPHONIA |
17 |
0.0003 |
| 666 |
HYPOGLYCAEMIA |
14 |
0.0003 |
| 667 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
52 |
0.0003 |
| 668 |
DEVICE USE ERROR |
10 |
0.0003 |
| 669 |
HUNGER |
4 |
0.0003 |
| 670 |
ORTHOSTATIC HYPOTENSION |
5 |
0.0003 |
| 671 |
WHITE BLOOD CELL COUNT INCREASED |
11 |
0.0003 |
| 672 |
DERMATITIS |
6 |
0.0003 |
| 673 |
SYRINGE ISSUE |
5 |
0.0003 |
| 674 |
CARPAL TUNNEL SYNDROME |
4 |
0.0003 |
| 675 |
DRUG WITHDRAWAL SYNDROME |
25 |
0.0003 |
| 676 |
HYPONATRAEMIA |
16 |
0.0003 |
| 677 |
SKIN REACTION |
4 |
0.0003 |
| 678 |
DIZZINESS |
141 |
0.0003 |
| 679 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
7 |
0.0003 |
| 680 |
JOINT INJURY |
6 |
0.0003 |
| 681 |
ILL-DEFINED DISORDER |
17 |
0.0003 |
| 682 |
SKIN CANCER |
6 |
0.0003 |
| 683 |
CONFUSIONAL STATE |
45 |
0.0003 |
| 684 |
NEEDLE ISSUE |
8 |
0.0003 |
| 685 |
BONE DISORDER |
5 |
0.0003 |
| 686 |
OSTEONECROSIS |
9 |
0.0003 |
| 687 |
DRUG DEPENDENCE |
44 |
0.0003 |
| 688 |
HAEMOGLOBIN DECREASED |
28 |
0.0003 |
| 689 |
ASCITES |
8 |
0.0003 |
| 690 |
GAIT DISTURBANCE |
52 |
0.0003 |
| 691 |
ANGIOEDEMA |
12 |
0.0003 |
| 692 |
CONTUSION |
26 |
0.0003 |
| 693 |
NEUTROPHIL COUNT DECREASED |
11 |
0.0003 |
| 694 |
SKIN HAEMORRHAGE |
4 |
0.0003 |
| 695 |
TRANSAMINASES INCREASED |
6 |
0.0003 |
| 696 |
PULMONARY MASS |
4 |
0.0003 |
| 697 |
HEPATIC STEATOSIS |
5 |
0.0003 |
| 698 |
COLON CANCER |
4 |
0.0003 |
| 699 |
EYE PRURITUS |
9 |
0.0003 |
| 700 |
SPEECH DISORDER |
14 |
0.0003 |
| 701 |
LOSS OF CONSCIOUSNESS |
34 |
0.0003 |
| 702 |
COLITIS |
10 |
0.0003 |
| 703 |
TOXIC EPIDERMAL NECROLYSIS |
4 |
0.0003 |
| 704 |
PLEURAL EFFUSION |
16 |
0.0003 |
| 705 |
HEART RATE INCREASED |
26 |
0.0003 |
| 706 |
LOWER LIMB FRACTURE |
5 |
0.0003 |
| 707 |
DEVICE RELATED INFECTION |
4 |
0.0003 |
| 708 |
GLAUCOMA |
5 |
0.0003 |
| 709 |
PERICARDIAL EFFUSION |
6 |
0.0003 |
| 710 |
BLOOD BILIRUBIN INCREASED |
7 |
0.0003 |
| 711 |
ANKLE FRACTURE |
4 |
0.0003 |
| 712 |
FALL |
86 |
0.0003 |
| 713 |
WHITE BLOOD CELL COUNT DECREASED |
28 |
0.0003 |
| 714 |
RASH MACULAR |
9 |
0.0003 |
| 715 |
CARDIAC DISORDER |
24 |
0.0003 |
| 716 |
CHOKING |
5 |
0.0003 |
| 717 |
ORAL HERPES |
5 |
0.0003 |
| 718 |
BONE PAIN |
15 |
0.0003 |
| 719 |
BLOOD PRESSURE DECREASED |
17 |
0.0003 |
| 720 |
SKIN FISSURES |
5 |
0.0003 |
| 721 |
FLUSHING |
26 |
0.0003 |
| 722 |
DISABILITY |
5 |
0.0003 |
| 723 |
UPPER LIMB FRACTURE |
5 |
0.0003 |
| 724 |
PANCYTOPENIA |
14 |
0.0003 |
| 725 |
PAIN |
153 |
0.0002 |
| 726 |
SKIN EXFOLIATION |
21 |
0.0002 |
| 727 |
NERVOUSNESS |
13 |
0.0002 |
| 728 |
HEPATITIS C |
3 |
0.0002 |
| 729 |
INJECTION SITE SWELLING |
19 |
0.0002 |
| 730 |
HYPERSENSITIVITY |
46 |
0.0002 |
| 731 |
PRESYNCOPE |
6 |
0.0002 |
| 732 |
TASTE DISORDER |
5 |
0.0002 |
| 733 |
MALAISE |
108 |
0.0002 |
| 734 |
COLITIS ULCERATIVE |
11 |
0.0002 |
| 735 |
BACK DISORDER |
4 |
0.0002 |
| 736 |
PANCREATITIS |
13 |
0.0002 |
| 737 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
7 |
0.0002 |
| 738 |
MANIA |
4 |
0.0002 |
| 739 |
CHEST PAIN |
45 |
0.0002 |
| 740 |
GENERALISED OEDEMA |
3 |
0.0002 |
| 741 |
VENTRICULAR TACHYCARDIA |
4 |
0.0002 |
| 742 |
PHOTOSENSITIVITY REACTION |
4 |
0.0002 |
| 743 |
DRUG LEVEL INCREASED |
4 |
0.0002 |
| 744 |
ARTHRITIS |
19 |
0.0002 |
| 745 |
ILEUS |
3 |
0.0002 |
| 746 |
EXPOSURE DURING PREGNANCY |
15 |
0.0002 |
| 747 |
HAIR COLOUR CHANGES |
3 |
0.0002 |
| 748 |
PAIN IN EXTREMITY |
71 |
0.0002 |
| 749 |
DYSSTASIA |
7 |
0.0002 |
| 750 |
OEDEMA |
13 |
0.0002 |
| 751 |
ACUTE MYOCARDIAL INFARCTION |
7 |
0.0002 |
| 752 |
MOUTH ULCERATION |
5 |
0.0002 |
| 753 |
FACE OEDEMA |
4 |
0.0002 |
| 754 |
INJECTION SITE IRRITATION |
3 |
0.0002 |
| 755 |
ASTHENIA |
88 |
0.0002 |
| 756 |
ERECTILE DYSFUNCTION |
6 |
0.0002 |
| 757 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
6 |
0.0002 |
| 758 |
MUSCULOSKELETAL DISCOMFORT |
4 |
0.0002 |
| 759 |
DRUG INEFFECTIVE |
305 |
0.0002 |
| 760 |
PRURITUS GENERALISED |
5 |
0.0002 |
| 761 |
NIGHTMARE |
8 |
0.0002 |
| 762 |
DEEP VEIN THROMBOSIS |
15 |
0.0002 |
| 763 |
ALTERED STATE OF CONSCIOUSNESS |
5 |
0.0002 |
| 764 |
ANAEMIA |
44 |
0.0002 |
| 765 |
EYE PAIN |
13 |
0.0002 |
| 766 |
SWELLING FACE |
15 |
0.0002 |
| 767 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
12 |
0.0002 |
| 768 |
MUSCULOSKELETAL PAIN |
12 |
0.0002 |
| 769 |
EPILEPSY |
7 |
0.0002 |
| 770 |
APPLICATION SITE ERYTHEMA |
6 |
0.0002 |
| 771 |
DYSPNOEA |
129 |
0.0002 |
| 772 |
ANKYLOSING SPONDYLITIS |
3 |
0.0002 |
| 773 |
METASTASES TO LIVER |
4 |
0.0002 |
| 774 |
COLD SWEAT |
4 |
0.0002 |
| 775 |
LYMPHOCYTE COUNT DECREASED |
4 |
0.0002 |
| 776 |
HERPES ZOSTER |
13 |
0.0002 |
| 777 |
FEMUR FRACTURE |
7 |
0.0002 |
| 778 |
LYMPHADENOPATHY |
8 |
0.0002 |
| 779 |
HEAD DISCOMFORT |
4 |
0.0002 |
| 780 |
EYE HAEMORRHAGE |
3 |
0.0002 |
| 781 |
UNEVALUABLE EVENT |
17 |
0.0002 |
| 782 |
THIRST |
4 |
0.0002 |
| 783 |
FEAR |
6 |
0.0002 |
| 784 |
DIABETES MELLITUS |
17 |
0.0002 |
| 785 |
DISTURBANCE IN ATTENTION |
12 |
0.0002 |
| 786 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
45 |
0.0002 |
| 787 |
LOWER RESPIRATORY TRACT INFECTION |
10 |
0.0002 |
| 788 |
BALANCE DISORDER |
19 |
0.0002 |
| 789 |
HYPERGLYCAEMIA |
8 |
0.0002 |
| 790 |
RESPIRATORY ARREST |
6 |
0.0002 |
| 791 |
DRUG INTOLERANCE |
21 |
0.0002 |
| 792 |
ABNORMAL DREAMS |
6 |
0.0002 |
| 793 |
TREATMENT FAILURE |
18 |
0.0002 |
| 794 |
ARTHROPATHY |
12 |
0.0002 |
| 795 |
ATRIAL FIBRILLATION |
21 |
0.0002 |
| 796 |
INJECTION SITE PAIN |
66 |
0.0002 |
| 797 |
EYE SWELLING |
8 |
0.0002 |
| 798 |
THINKING ABNORMAL |
4 |
0.0002 |
| 799 |
WRONG TECHNIQUE IN DEVICE USAGE PROCESS |
10 |
0.0002 |
| 800 |
BURNING SENSATION |
15 |
0.0002 |
| 801 |
SWELLING |
20 |
0.0002 |
| 802 |
BLOOD TEST ABNORMAL |
3 |
0.0002 |
| 803 |
DEVICE OCCLUSION |
3 |
0.0002 |
| 804 |
OSTEOARTHRITIS |
9 |
0.0002 |
| 805 |
DIALYSIS |
3 |
0.0002 |
| 806 |
ARRHYTHMIA |
10 |
0.0002 |
| 807 |
SKIN DISORDER |
7 |
0.0002 |
| 808 |
URINARY RETENTION |
7 |
0.0002 |
| 809 |
OVERDOSE |
45 |
0.0002 |
| 810 |
HYPERTHYROIDISM |
3 |
0.0002 |
| 811 |
INFLUENZA LIKE ILLNESS |
17 |
0.0002 |
| 812 |
GASTROENTERITIS |
3 |
0.0002 |
| 813 |
UNDERDOSE |
15 |
0.0002 |
| 814 |
CHILLS |
24 |
0.0002 |
| 815 |
INJECTION SITE URTICARIA |
5 |
0.0002 |
| 816 |
LABORATORY TEST ABNORMAL |
6 |
0.0002 |
| 817 |
LIVER DISORDER |
9 |
0.0002 |
| 818 |
DRUG EFFECT LESS THAN EXPECTED |
3 |
0.0002 |
| 819 |
ACTIVITIES OF DAILY LIVING IMPAIRED |
4 |
0.0002 |
| 820 |
INJECTION SITE ERYTHEMA |
25 |
0.0002 |
| 821 |
IMMUNODEFICIENCY |
3 |
0.0002 |
| 822 |
PERIPHERAL SWELLING |
31 |
0.0002 |
| 823 |
BONE LOSS |
3 |
0.0002 |
| 824 |
HEPATIC FAILURE |
6 |
0.0002 |
| 825 |
CELLULITIS |
10 |
0.0002 |
| 826 |
BACK PAIN |
46 |
0.0002 |
| 827 |
BLOOD COUNT ABNORMAL |
3 |
0.0002 |
| 828 |
DEVICE FAILURE |
3 |
0.0002 |
| 829 |
PLATELET COUNT DECREASED |
21 |
0.0002 |
| 830 |
BONE MARROW FAILURE |
4 |
0.0002 |
| 831 |
THERAPY INTERRUPTED |
14 |
0.0002 |
| 832 |
INJECTION SITE RASH |
6 |
0.0002 |
| 833 |
MOBILITY DECREASED |
14 |
0.0002 |
| 834 |
THERAPY CESSATION |
10 |
0.0002 |
| 835 |
SKIN ULCER |
5 |
0.0002 |
| 836 |
RENAL DISORDER |
9 |
0.0002 |
| 837 |
DELUSION |
3 |
0.0002 |
| 838 |
HAEMATOMA |
5 |
0.0002 |
| 839 |
COGNITIVE DISORDER |
9 |
0.0002 |
| 840 |
BASAL CELL CARCINOMA |
3 |
0.0002 |
| 841 |
PANIC ATTACK |
7 |
0.0002 |
| 842 |
HAEMORRHAGE |
20 |
0.0002 |
| 843 |
RENAL IMPAIRMENT |
16 |
0.0002 |
| 844 |
DYSURIA |
7 |
0.0002 |
| 845 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
3 |
0.0002 |
| 846 |
MYALGIA |
32 |
0.0002 |
| 847 |
EPISTAXIS |
14 |
0.0002 |
| 848 |
CARDIAC FAILURE CONGESTIVE |
15 |
0.0002 |
| 849 |
THROMBOSIS |
15 |
0.0002 |
| 850 |
RECTAL HAEMORRHAGE |
8 |
0.0002 |
| 851 |
POOR QUALITY SLEEP |
4 |
0.0002 |
| 852 |
CHEST DISCOMFORT |
19 |
0.0002 |
| 853 |
FREQUENT BOWEL MOVEMENTS |
5 |
0.0002 |
| 854 |
INJURY |
13 |
0.0002 |
| 855 |
THROAT TIGHTNESS |
5 |
0.0002 |
| 856 |
BLOOD PRESSURE INCREASED |
28 |
0.0002 |
| 857 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
13 |
0.0002 |
| 858 |
DRUG DOSE OMISSION |
30 |
0.0002 |
| 859 |
THERAPEUTIC RESPONSE DECREASED |
11 |
0.0002 |
| 860 |
HAEMATOCHEZIA |
10 |
0.0002 |
| 861 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
4 |
0.0002 |
| 862 |
RASH MACULO-PAPULAR |
4 |
0.0002 |
| 863 |
GASTROINTESTINAL HAEMORRHAGE |
15 |
0.0002 |
| 864 |
FEELING HOT |
11 |
0.0002 |
| 865 |
PULMONARY EMBOLISM |
17 |
0.0002 |
| 866 |
GLOSSODYNIA |
4 |
0.0002 |
| 867 |
BLISTER |
10 |
0.0002 |
| 868 |
NEUTROPENIA |
24 |
0.0002 |
| 869 |
CIRCULATORY COLLAPSE |
3 |
0.0002 |
| 870 |
INJECTION SITE BRUISING |
14 |
0.0002 |
| 871 |
INTERNATIONAL NORMALISED RATIO INCREASED |
5 |
0.0002 |
| 872 |
HAEMATURIA |
6 |
0.0002 |
| 873 |
ADVERSE EVENT |
16 |
0.0002 |
| 874 |
DEVICE DEFECTIVE |
3 |
0.0002 |
| 875 |
GENERAL PHYSICAL HEALTH DETERIORATION |
20 |
0.0002 |
| 876 |
DEVICE USE ISSUE |
3 |
0.0002 |
| 877 |
HYPERKALAEMIA |
6 |
0.0002 |
| 878 |
ARTHRALGIA |
71 |
0.0002 |
| 879 |
DRUG ERUPTION |
3 |
0.0002 |
| 880 |
AMNESIA |
11 |
0.0002 |
| 881 |
PRODUCT PRESCRIBING ERROR |
4 |
0.0002 |
| 882 |
GOUT |
3 |
0.0002 |
| 883 |
MUSCULAR WEAKNESS |
19 |
0.0002 |
| 884 |
HYPOAESTHESIA |
25 |
0.0002 |
| 885 |
BLOOD PRESSURE FLUCTUATION |
4 |
0.0002 |
| 886 |
APHASIA |
5 |
0.0002 |
| 887 |
DRUG EFFECT INCOMPLETE |
6 |
0.0002 |
| 888 |
ACCIDENTAL OVERDOSE |
6 |
0.0002 |
| 889 |
INJECTION SITE MASS |
6 |
0.0002 |
| 890 |
DEVICE DISLOCATION |
7 |
0.0002 |
| 891 |
AGEUSIA |
4 |
0.0002 |
| 892 |
NERVOUS SYSTEM DISORDER |
5 |
0.0002 |
| 893 |
HEPATIC CIRRHOSIS |
3 |
0.0002 |
| 894 |
FRACTURE |
3 |
0.0002 |
| 895 |
ACNE |
12 |
0.0002 |
| 896 |
PRODUCT COMPLAINT |
4 |
0.0002 |
| 897 |
HAEMATEMESIS |
4 |
0.0002 |
| 898 |
CARDIOVASCULAR DISORDER |
4 |
0.0002 |
| 899 |
FEELING JITTERY |
3 |
0.0002 |
| 900 |
CONVULSION |
9 |
0.0002 |
| 901 |
DEVICE MALFUNCTION |
11 |
0.0002 |
| 902 |
MOVEMENT DISORDER |
5 |
0.0002 |
| 903 |
DRUG RESISTANCE |
4 |
0.0002 |
| 904 |
NIGHT SWEATS |
5 |
0.0002 |
| 905 |
HERNIA |
3 |
0.0002 |
| 906 |
ERUCTATION |
3 |
0.0002 |
| 907 |
NO ADVERSE EVENT |
28 |
0.0002 |
| 908 |
EXPOSURE VIA SKIN CONTACT |
4 |
0.0002 |
| 909 |
DIPLOPIA |
4 |
0.0002 |
| 910 |
INCORRECT DOSE ADMINISTERED |
35 |
0.0002 |
| 911 |
DEAFNESS |
4 |
0.0002 |
| 912 |
MEMORY IMPAIRMENT |
21 |
0.0002 |
| 913 |
ALOPECIA |
30 |
0.0002 |
| 914 |
INCORRECT DOSE ADMINISTERED BY DEVICE |
4 |
0.0002 |
| 915 |
EYE DISORDER |
5 |
0.0002 |
| 916 |
THROMBOCYTOPENIA |
17 |
0.0002 |
| 917 |
EXPIRED PRODUCT ADMINISTERED |
5 |
0.0002 |
| 918 |
DRY SKIN |
20 |
0.0001 |
| 919 |
CARDIAC FAILURE |
12 |
0.0001 |
| 920 |
MENSTRUATION IRREGULAR |
4 |
0.0001 |
| 921 |
INJECTION SITE PRURITUS |
10 |
0.0001 |
| 922 |
PAIN OF SKIN |
4 |
0.0001 |
| 923 |
TYPE 2 DIABETES MELLITUS |
5 |
0.0001 |
| 924 |
DISEASE RECURRENCE |
7 |
0.0001 |
| 925 |
DEATH |
124 |
0.0001 |
| 926 |
NEOPLASM PROGRESSION |
5 |
0.0001 |
| 927 |
DISEASE PROGRESSION |
17 |
0.0001 |
| 928 |
DEMENTIA |
4 |
0.0001 |
| 929 |
IMPAIRED WORK ABILITY |
3 |
0.0001 |
| 930 |
DRY EYE |
7 |
0.0001 |
| 931 |
ANGINA PECTORIS |
4 |
0.0001 |
| 932 |
OEDEMA PERIPHERAL |
17 |
0.0001 |
| 933 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
3 |
0.0001 |
| 934 |
INJECTION SITE HAEMORRHAGE |
11 |
0.0001 |
| 935 |
WRONG TECHNIQUE IN DRUG USAGE PROCESS |
5 |
0.0001 |
| 936 |
VISUAL IMPAIRMENT |
17 |
0.0001 |
| 937 |
NEUROPATHY PERIPHERAL |
13 |
0.0001 |
| 938 |
PSYCHOTIC DISORDER |
4 |
0.0001 |
| 939 |
HEPATOTOXICITY |
3 |
0.0001 |
| 940 |
PULMONARY OEDEMA |
6 |
0.0001 |
| 941 |
ADVERSE DRUG REACTION |
12 |
0.0001 |
| 942 |
PARAESTHESIA |
21 |
0.0001 |
| 943 |
HOT FLUSH |
10 |
0.0001 |
| 944 |
COMPLETED SUICIDE |
11 |
0.0001 |
| 945 |
BRADYCARDIA |
7 |
0.0001 |
| 946 |
ERYTHEMA |
27 |
0.0001 |
| 947 |
SKIN IRRITATION |
6 |
0.0001 |
| 948 |
INJECTION SITE REACTION |
9 |
0.0001 |
| 949 |
RASH PRURITIC |
7 |
0.0001 |
| 950 |
SWOLLEN TONGUE |
4 |
0.0001 |
| 951 |
COMA |
6 |
0.0001 |
| 952 |
MEDICATION ERROR |
7 |
0.0001 |
| 953 |
MUSCULOSKELETAL STIFFNESS |
11 |
0.0001 |
| 954 |
CHOLELITHIASIS |
4 |
0.0001 |
| 955 |
IMPAIRED HEALING |
4 |
0.0001 |
| 956 |
CARDIO-RESPIRATORY ARREST |
5 |
0.0001 |
| 957 |
GASTRIC DISORDER |
4 |
0.0001 |
| 958 |
HEART RATE DECREASED |
4 |
0.0001 |
| 959 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
8 |
0.0001 |
| 960 |
MATERNAL EXPOSURE DURING PREGNANCY |
10 |
0.0001 |
| 961 |
PRODUCT ADHESION ISSUE |
4 |
0.0001 |
| 962 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
5 |
0.0001 |
| 963 |
DRUG EFFECT DECREASED |
6 |
0.0001 |
| 964 |
PRODUCT QUALITY ISSUE |
15 |
0.0001 |
| 965 |
MALIGNANT NEOPLASM PROGRESSION |
11 |
0.0001 |
| 966 |
BLOOD CHOLESTEROL INCREASED |
5 |
0.0001 |
| 967 |
PSORIASIS |
14 |
0.0001 |
| 968 |
HEPATIC FUNCTION ABNORMAL |
4 |
0.0001 |
| 969 |
INCORRECT DRUG ADMINISTRATION DURATION |
3 |
0.0001 |
| 970 |
MULTIPLE SCLEROSIS |
5 |
0.0001 |
| 971 |
PRODUCT SUBSTITUTION ISSUE |
6 |
0.0001 |
| 972 |
LEUKOPENIA |
5 |
0.0001 |
| 973 |
SKIN BURNING SENSATION |
7 |
0.0001 |
| 974 |
RHEUMATOID ARTHRITIS |
11 |
0.0001 |
| 975 |
DYSGEUSIA |
7 |
0.0001 |
| 976 |
HYPOTHYROIDISM |
3 |
0.0001 |
| 977 |
THROAT IRRITATION |
4 |
0.0001 |
| 978 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
3 |
0.0001 |
| 979 |
BLOOD GLUCOSE INCREASED |
16 |
0.0001 |
| 980 |
CEREBRAL HAEMORRHAGE |
3 |
0.0001 |
| 981 |
BLOOD GLUCOSE DECREASED |
4 |
0.0001 |
| 982 |
CEREBROVASCULAR ACCIDENT |
14 |
0.0001 |
| 983 |
PRODUCT STORAGE ERROR |
7 |
0.0001 |
| 984 |
DEVICE DIFFICULT TO USE |
5 |
0.0001 |
| 985 |
NEOPLASM MALIGNANT |
5 |
0.0001 |
| 986 |
EXTRA DOSE ADMINISTERED |
3 |
0.0001 |
| 987 |
DRY MOUTH |
6 |
0.0001 |
| 988 |
VERTIGO |
4 |
0.0001 |
| 989 |
JOINT SWELLING |
7 |
0.0001 |
| 990 |
CATARACT |
3 |
0.0001 |
| 991 |
ACCIDENTAL EXPOSURE TO PRODUCT |
4 |
0.0000 |